ArticleEuropean radiology2022
Development and evaluation of machine learning models based on X-ray radiomics for the classification and differentiation of malignant and benign bone tumors.
Article in European radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The diagnostic value of machine learning for the classification of malignant bone tumor: a systematic evaluation and meta-analysis.Frontiers in oncology · 2023Pooled it
- Performance of multimodal large language models for the detection and characterization of bone lesions on radiographs.Diagnostic and interventional radiology (Ankara, Turkey) · 2026Article
- Imaging features and differential diagnosis of benign osseous cystic lesions: Aneurysmal bone cyst versus femoral neck herniation pit.Pakistan journal of medical sciences · 2026Article
- A clinical-radiomics model based on multiparametric MRI for discriminating solitary primary spinal tumors from solitary spinal metastases.BMC medical imaging · 2026Article
- Medical image pretraining-based transfer learning for generalizable and robust diagnosis of bone tumors on radiographs: a multi-center study.Insights into imaging · 2026Article
- Deep learning ensemble models for CT-based differentiation of malignant and benign sacral bone tumors: development and evaluation.Insights into imaging · 2026Article
- Current Position of Nuclear Medicine Imaging in Primary Bone Tumors.Diagnostics (Basel, Switzerland) · 2025Review
- Enhancing YOLOv11 with Large Kernel Attention and Multi-Scale Fusion for Accurate Small and Multi-Lesion Bone Tumor Detection in Radiographs.Diagnostics (Basel, Switzerland) · 2025Article
- Artificial Intelligence in Primary Malignant Bone Tumor Imaging: A Narrative Review.Diagnostics (Basel, Switzerland) · 2025Review
- Revolutionising osseous biopsy: the impact of artificial intelligence in the era of personalized medicine.The British journal of radiology · 2025Review
- Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review.BMC medical research methodology · 2025Article
- Comparison of Resampling Methods and Radiomic Machine Learning Classifiers for Predicting Bone Quality Using Dual-Energy X-Ray Absorptiometry.Diagnostics (Basel, Switzerland) · 2025Article
- Exploiting biochemical data to improve osteosarcoma diagnosis with deep learning.Health information science and systems · 2024Article
- Deep learning-based detection of primary bone tumors around the knee joint on radiographs: a multicenter study.Quantitative imaging in medicine and surgery · 2024Article
- A CT-based radiomics nomogram for predicting histologic grade and outcome in chondrosarcoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
- Deep learning for differentiation of osteolytic osteosarcoma and giant cell tumor around the knee joint on radiographs: a multicenter study.Insights into imaging · 2024Article
- Artificial intelligence and machine learning applications for the imaging of bone and soft tissue tumors.Frontiers in radiology · 2024Review
- Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review.Cancers · 2023Review
- Engineered nanomaterials enhance drug delivery strategies for the treatment of osteosarcoma.Frontiers in pharmacology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo develop and validate machine learning models to distinguish between benign and malignant bone lesions and compare the performance to radiologists.
methodsIn 880 patients (age 33.1 ± 19.4 years, 395 women) diagnosed with malignant (n = 213, 24.2%) or benign (n = 667, 75.8%) primary bone tumors, preoperative radiographs were obtained, and the diagnosis was established using histopathology. Data was split 70%/15%/15% for training, validation, and internal testing. Additionally, 96 patients from another institution were obtained for external testing. Machine learning models were developed and validated using radiomic features and demographic information. The performance of each model was evaluated on the test sets for accuracy, area under the curve (AUC) from receiver operating characteristics, sensitivity, and specificity. For comparison, the external test set was evaluated by two radiology residents and two radiologists who specialized in musculoskeletal tumor imaging.
resultsThe best machine learning model was based on an artificial neural network (ANN) combining both radiomic and demographic information achieving 80% and 75% accuracy at 75% and 90% sensitivity with 0.79 and 0.90 AUC on the internal and external test set, respectively. In comparison, the radiology residents achieved 71% and 65% accuracy at 61% and 35% sensitivity while the radiologists specialized in musculoskeletal tumor imaging achieved an 84% and 83% accuracy at 90% and 81% sensitivity, respectively.
conclusionsAn ANN combining radiomic features and demographic information showed the best performance in distinguishing between benign and malignant bone lesions. The model showed lower accuracy compared to specialized radiologists, while accuracy was higher or similar compared to residents. KEY POINTS: • The developed machine learning model could differentiate benign from malignant bone tumors using radiography with an AUC of 0.90 on the external test set. • Machine learning models that used radiomic features or demographic information alone performed worse than those that used both radiomic features and demographic information as input, highlighting the importance of building comprehensive machine learning models. • An artificial neural network that combined both radiomic and demographic information achieved the best performance and its performance was compared to radiology readers on an external test set.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.